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ABSTRACT  
A prospective randomized study was performed on 100 
Sudanese children presenting for elective infra umbilical surgical 
procedures under general anesthesia. All patients were of ASA 
grade I and II. Within the age group 1-12 years. The postoperative 
analgesic effect of two drugs bupivacaine and paracetamol was 
compared. Patients in the study were randomly allocated into two 
groups. 50 patients in each group. Patients in group A received 
caudal bupivacaine (0.5 ml/kg) (0.25%) of bupivacaine. Those in 
group B received 20 mg/kg paracetamol rectally. 18% of patients in 
group A needed postoperative analgesia in the first 24 hours,  
44.4% of them received intra-muscular pethedine while 55.6% 
received oral paracetamol.  
  64% of patients in group B needed postoperative analgesia in 
the first 24 hours, 60.8% of them received intra-muscular 
pethedine while 39.2% of patients received oral paracetamol.  
- Need for postoperative analgesia in the first 24 hours between 
the two groups is significantly different.  
-  There was significant difference in time of administration of 
postoperative analgesic between the two groups. 
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- There was no significant difference in the type of post-operative 
analgesic between the two groups.      
In conclusion caudal bupivacaine is more effective and patients 
were satisfied with it more than rectal paracetamol.  
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  ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﺔ
   
ﻋﻨـﺩ ﻫﺫﻩ ﺩﺭﺍﺴﺔ ﺃﻤﺎﻤﻴﺔ ﺘﺠﺭﻴﺒﻴﺔ ﻓﻲ ﻤﻌﺎﻟﺠﺔ ﺍﻷﻟﻡ ﺍﻟﺫﻱ ﻴﺤﺩﺙ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ ﺍﻟﺠﺭﺍﺤﻴـﺔ 
  . ﻭﺫﻟﻙ ﺒﺎﺴﺘﺨﺩﺍﻡ ﻋﻘﺎﺭﻴﻥ ﻭﻤﻘﺎﺭﻨﺔ ﻤﺩﻯ ﻓﻌﺎﻟﻴﺘﻬﻤﺎﺍﻷﻁﻔﺎل 
ﺘﻡ ﺍﺨﺘﻴﺎﺭ ﻤﺎﺌﺔ ﻁﻔل ﻤﺭﻴﺽ ﻋﺸﻭﺍﺌﻴﺎﹰ ﻟﻠﺩﺭﺍﺴﺔ ﻭﻫﻡ ﻴﻨﺩﺭﺠﻭﻥ ﻓﻲ ﻋﻤﻠﻴـﺎﺕ ﺠﺭﺍﺤﻴـﺔ 
ﻤﺭﻀـﻰ . ﻭﻥ ﻤـﺭﻴﺽ ﻓـﻲ ﻜـل ﻤﺠﻤﻭﻋـﺔ ﺨﻤﺴ. ﺍﺨﺘﻴﺎﺭﻴﺔ ﻭﻗﺩ ﺘﻡ ﺘﻘﺴﻴﻤﻬﻡ ﺇﻟﻰ ﻤﺠﻤﻭﻋﺘﻴﻥ 
 ﺒﻌﺩ ﻓﻰ ﺍﻟﻤﻨﻁﻘﺔ ﺍﻟﻌﺠﺯﻴﺔ (ﺇﺒﻴﺩﻭﺭﺍل)ﺘﻡ ﺤﻘﻨﻬﻡ ﺒﻌﻘﺎﺭ ﺍﻟﺒﻴﻭﻴﻔﺎﻜﻴﻥ ﻓﻭﻕ ﺍﻷﻡ ﺍﻟﺠﺎﻓﻴﺔ ( ﺃ)ﺍﻟﻤﺠﻤﻭﻋﺔ 
ﻤﺭﻀـﻰ .  ﻟﻠﻌﻘـﺎﺭ %52.0ﻜﺠﻡ ﺒﺘﺭﻜﻴـﺯ /  ﻤﻠﺠﻡ 5.0ﺇﺠﺭﺍﺀ ﺍﻟﺘﺨﺩﻴﺭ ﺍﻟﻌﻤﻭﻤﻲ ﺒﺠﺭﻋﺔ ﻗﺩﺭﻫﺎ 
ﻜﺠﻡ ﺒﻌـﺩ / ﻠﺠﻡ ﻤ 02ﺘﻡ ﻭﻀﻊ ﻋﻘﺎﺭ ﺒﺎﺭﺍﺴﻴﺘﺎﻤﻭل ﺩﺍﺨل ﺍﻟﺸﺭﺝ ﺒﺠﺭﻋﺔ ﻗﺩﺭﻫﺎ ( ﺏ)ﺍﻟﻤﺠﻤﻭﻋﺔ 
ﺍﺤﺘﺎﺠﻭﺍ ﺇﻟﻰ ﻤﺯﻴل ﺃﻟﻡ ﺇﻀﺎﻓﻲ ﻓـﻲ ( ﺃ)ﻤﻥ ﻤﺭﻀﻰ ﺍﻟﻤﺠﻤﻭﻋﺔ % 81. ﺇﺠﺭﺍﺀ ﺍﻟﺘﺨﺩﻴﺭ ﺍﻟﻌﻤﻭﻤﻲ 
ﻤﻨﻬﻡ ﺘﻡ ﺤﻘـﻨﻬﻡ ﺒﻌﻘـﺎﺭ ﺍﻟﺒﺜـﺩﻴﻥ % 4.44ﺨﻼل ﺍﻷﺭﺒﻊ ﻭﺍﻟﻌﺸﺭﻴﻥ ﺴﺎﻋﺔ ﺍﻷﻭﻟﻰ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ، 
  . ﻤﻨﻬﻡ ﺃﻋﻁﻰ ﻋﻘﺎﺭ ﺒﺎﺭﺍﺴﻴﺘﺎﻤﻭل ﺒﺎﻟﻔﻡ% 6.55ﺒﺎﻟﻌﻀل ﻭ
 ﻤﺯﻴل ﺃﻟﻡ ﺇﻀﺎﻓﻲ ﻓﻲ ﺨـﻼل ﺍﻷﺭﺒـﻊ ﺍﺤﺘﺎﺠﻭﺍ ﺇﻟﻰ ( ﺏ)ﻤﻥ ﻤﺭﻀﻰ ﺍﻟﻤﺠﻤﻭﻋﺔ % 64
% 2.93ﻤﻨﻬﻡ ﺘﻡ ﺤﻘﻨﻬﻡ ﺒﻌﻘﺎﺭ ﺍﻟﺒﺜﺩﻴﻥ ﺒﺎﻟﻌـﻀل ﻭ % 8.06ﻭﺍﻟﻌﺸﺭﻴﻥ ﺴﺎﻋﺔ ﺍﻷﻭﻟﻰ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ، 
  . ﻤﻨﻬﻡ ﺃﻋﻁﻰ ﻋﻘﺎﺭ ﺒﺎﺭﺍﺴﻴﺘﺎﻤﻭل ﺒﺎﻟﻔﻡ
ﻫﻨﺎﻙ ﻓﺭﻕ ﺇﺤﺼﺎﺌﻲ ﻓﻲ ﺍﻟﺤﻭﺠﺔ ﺇﻟﻰ ﻤﺯﻴل ﺃﻟﻡ ﻓﻲ ﺨﻼل ﺍﻷﺭﺒـﻊ ﻭﺍﻟﻌـﺸﺭﻴﻥ ﺴـﺎﻋﺔ 
ﻭﻫﻨﺎﻙ ﻓﺭﻕ . ﺌﻲ ﻓﻲ ﻨﻭﻉ ﻤﺯﻴل ﺍﻷﻟﻡ ﺍﻹﻀﺎﻓﻲ ﻟﻴﺱ ﻫﻨﺎﻙ ﻓﺭﻕ ﺇﺤﺼﺎ . ﺍﻷﻭﻟﻰ ﺒﻴﻥ ﺍﻟﻤﺠﻤﻭﻋﺘﻴﻥ 
  . ﺯﻤﻥ ﺤﻘﻨﻪ ﺒﻴﻥ ﺍﻟﻤﺠﻤﻭﻋﺘﻴﻥﺍﺤﺼﺎﺌﻲ ﻓﻰ 
ﺨﻼﺼﺔ ﺍﻟﺩﺭﺍﺴﺔ ﺃﻥ ﺤﻘﻥ ﺍﻟﺒﻴﻭﺒﻔﺎﻜﻴﻥ ﺨﺎﺭﺝ ﺍﻷﻡ ﺍﻟﺠﺎﻓﻴﺔ ﺃﻜﺜﺭ ﻓﻌﺎﻟﻴﺔ ﻭﺭﻀﻰ ﺍﻟﻤﺭﻀﻰ 
  .   ﺃﻜﺜﺭ ﻤﻥ ﻭﻀﻊ ﻋﻘﺎﺭ ﺍﻟﺒﺎﺭﺍﺴﻴﺘﺎﻤﻭل ﻓﻲ ﺍﻟﺸﺭﺝ
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INTRODUCTION  
 
Pain is an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage.(1) Provision of 
pain relief after an operation is essential in children to permit rapid 
discharge from hospital of a comfortable patient who is free of 
complications, with parents who are reassured of their child well- 
being in the immediate and late post-operative period.  
After having proved that children perceive, respond to and 
remember pain similarly to adults, several analgesic techniques 
have been proposed aiming at protecting children against 
metabolic, haemodynamic and psychological changes caused by 
surgical procedures.  
Post-operative pain differs from other types of pain in that 
it is transient and improves in short time. Degree, effect and 
duration vary greatly. Young and elderly who are emotionally 
stable show lesser responses.(2)  
Postoperative pain is associated with many adverse 
effects: it reduces tidal volume, vital capacity and functional 
residual capacity. Sympathetic over activity induced by pain leads 
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to tachycardia, hypertension and increases cardiac work and 
myocardial oxygen demand.  
Caudal analgesia is used successfully in the provision of 
pain relief in children, but occasionally it may result in adverse 
effects as a result of more extensive block than is necessary. 
Caudal block may relief early post-operative pain but in the later 
period, systemic analgesics may be needed.(3)  
Rectal administration of drugs in children is safe and 
provides convenient route for drug absorption. Paracetamal is 
available in pediatric suppository formulation. It provides analgesia 
in post-operative period, in addition respiratory depressant effects 
of opioids are avoided.(4)  
In this study two drugs bupivacaine and paracetamol were 
compared to identify the most suitable drug as far as patient 
satisfaction and safety are concerned.(4) 
 
 
 
 
 
 
 
 3
LITERATURE REVIEW  
Pain is defined as an unpleasant sensory and emotional 
experience associated with acute tissue damage. Pain may be 
acute or chronic or a symptom of disease.  
Acute pain from nociceptive stimulation is an important 
biological warning that something is wrong. Persistent pain may 
become chronic, imposing emotional, physical, economic and 
social stress. It is one of the most costy health care problems for 
the society.(5)  
Anatomy of pain:  
Structures that mediate our appreciation of, and response 
to pain are categorized into two groups: Those that deal with the 
response to pain as an unpleasant sensation, and sensory 
discriminative aspects of pain.(6)  
The cortex: a host of connections link higher cortical 
structures with pain-centered nuclei in the thalamus and 
brainstem. The major cortical pathways are:  
- Sensory cortex S I.  
- Secondary sensory cortex S II.  
- Anterior insula.  
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- Cingulate gyrus.  
• All six layers of dorsal horn mainly  I, II and V rex-laminae. 
The thalamus: Several of its multiple nuclei are concerned with 
pain. The lateral nuclei deal with sensory discriminative aspects, 
the medial ones with affective pain (the internal medullary lamina 
bounds the dorsomedial nucleus laterally and separates it from the 
anterior nuclei. Within the internal medullarly lamina are the inter 
laminar nuclei, including centromedian and centrolateral nuclei).  
The midbrain: Here most of circuitry is involved in affective pain 
with extensive connections to the reticular system of the 
brainstem:  
• The peri-aqueductal grey matter.  
• Deep layers of superior colliculus.  
• The red nucleus.  
• Pretectal nuclei (anterior and posterior).  
• Nucleus of Darkschewitsch.  
• Interstitial nucleus of Cajal.  
• Intercolliculus nucleus cuniformis and Edinger-Westphal 
nucleus.  
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The pons: The most important pain related nucleus in the pons is 
the locus coeruleus. This is full of noradrenaline containing 
neurons, which projects to a variety of brainstem structures that 
modulate pain through pathways that descend to the spinal cord.  
The medulla: This is also involved in motivational, affective 
aspects of pain. The nucleus gigantocellularis and related nuclei, 
the lateral reticular nucleus and a variety of other nuclei. The raphe 
nuclei in the descending pathways suppress pain.   
Peripheral nerve sensitivity:  
Tissue damage results in a drop in pH and release of 
chemicals e.g. histamine to which small myelinated fibers are 
sensitive, fibers respond and generated electrical impulses that 
travel along the nerve to the dorsal horn of spinal cord.  
On entering the spinal cord the pain signals take two 
different pathways to the brain via neospinothalmic tracts and 
paleospinothalamic tracts.  
Nerve fibers within the tract terminate mainly in lamina I 
(marginalis) of dorsal horn where they excite second order nervous 
of neospinothalamic tract. They give rise to long fibers that cross 
immediately to the opposite side, through the anterior comissure. 
They then pass to the brain in the anterio-lateral columns. 
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Pain physiology:  
Pain originates at the level of the tissues in various 
nociceptors. These nociceptors transmit to the spinal cord and via 
two types of nerve fibers. Small myelinated A delta fibers transmits 
fast responses to the CNS. This, which facilitates appropriate 
responses for the patient, e.g. withdrawal of affected limb from 
noxious insult.(7) Small ummyelinated C-fibers transmits 
information slowly and produce delayed responses resulting in dull 
aching pain.  
Persistent nociception recruits and amplifies signals, which 
are transmitted from spinal cord to the brain resulting in pain. 
Changes in the spinal cord include reduced threshold responses 
and expanded receptive fields, which participate in " wind up" 
response, which results in significant pain experience at a later 
time.(8) 
Types of pain:  
• Somatic pain: It is sharp, and well localized like pain arising 
from the skin, skeletal muscles and peritoneum, e.g. due 
surgical incision, second stage of labour pain and peritoneal 
irritation respectively.(9)  
• Visceral pain: Pain receptors in the viscera are similar to those 
in the skin but are more sparsely distributed. Any event causing 
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stimulation of nerve endings in a viscus causes intense pain 
that is diffuse, poorly localized and associated with nausea and 
signs of autonomic nervous system activation. It radiates and 
causes referred pain at the same dermatomal origin as the 
affected viscus. Causes of viseral pain includes, ischaemia, 
ligamantal tears, smooth muscle spasms. Colicky type of 
visceral pain accompanies gastroenteritis, gall bladder and 
ureteral obstruction, menstruation, 1st stage of labour.(1)  
Postoperative pain:   
Postoperative pain is a complex physiologic reaction to 
tissue injury, visceral distention or disease. It results in an 
unpleasant, unwanted sensory and emotional experience. It is an 
extraoridinary complex sensation, which is difficult to define and 
measure. It may be defined as the sensory appreciation of afferent 
nociceptive stimulation, eliciting an effective autonomic 
component.(1)  
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The Ven diagram below shows the interrelationship 
between emotional rational and physical components of pain: the 
shaded area represents the quantum of suffering experienced by 
the patient. 
 
 
 
 
Pain pathways:  
a- Neural pathway:  
First pain responses are conveyed from the periphery to 
the dorsal horn of the spinal cord in small myelinated fibers (A-
delta). Second pain is conveyed in non myelinated (C) fibers. 
b-  Spinal cord pathways: 
Initial connections: 70% of fibers enter the dorsal root, the 
remaining enter the ventral (motor) root. Grey matter in the spinal 
cord has ten laminae. Most important in relation to pain are:   
- Lamina I marginal zone.  
- Lamina II substansia gelatinosa.  
- Lamina V.  
- Lamina VII & VIII intermediate spinal grey matter. 
  
Emotional Rational 
Physical 
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• Two main pathways of pain are:  
1- Primitive spino-reticlo-diencephalic tract. Impulses pass from 
type C fibers to several second order neurons.  
2- New neospinothalamic tract. Here most of the fibers are taken 
from lamina I & V, and mediate "first" pain.  
Second order neurons:  
1- Nerve cells that respond to gentle stimuli as well as pain, 
increasing their response as the stimulus increases. This is 
Wide Dynamic Range cell. WDR are found in lamina V.  It has 
a wind up action, which occurs with repetitive stimulation via C 
fibers. Each added stimulus increases the response of WDR 
cell. It may be related to stimulation of glutamate receptors.  
2- Nociceptive specific neurons found in lamina I responds to 
noxious stimuli.  
3- Complex neurons (receives many inputs. Located in lamina VII 
and VIII.  
Spinal pathways connections mediating "gating" are 
present here. Painful stimulation coming into the cord on C fibers 
can be modified by other inputs, which come from A delta fibers 
and B fibers.  
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This has practical consequences e.g.:  
• Transcutaneous electrical nerve stimulation (TENS) works by 
high frequency, low amplitude stimulation of larger fibers, which 
inhibits transmission of pain through gates.  
• Dorsal column stimulation.  
• Making acupuncture effective.  
• Rubbing skin locally to decrease pain.(10)  
c-  Higher ascending pathways:  
i- Spino-reticulo diencephalic pathway (old): - It mainly ends in 
the reticular system of the brain stem as well as medial 
nuclei of thalamus. Emotional affective response to pain are 
due to projections that go from medial nuclei of thalamus to 
most of the cortex (anterior cingulate gyrus). 
ii-  Spinothalamic tract (new): connection here go to the 
sensory cortex (post central gyrus), but it is not the main 
pathway, since lesion along the pathway here do not cancel 
sensation of pain, but may cause severe pain due to 
possible damage of inhibitory pathway.(11)      
d- Descending pathways:  
Descending modulation of pain sensation originates from 3 
main areas: the cortex, the thalamus and the brainstem.  Fibers 
pass from PAG (periaqueductal greymatter) to the reticular 
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formation of the medulla (Ventromedulla) where connections are 
serotonergic and form axons descending in dorsolateral funicules 
of the spinal cord to end in interneurons next to substansia 
gelatinosa.  
The synapses are encephalergic (lamina II) in the spinal 
cord. Stimulation of this system causes inhibition of incoming pain 
impulses therefore, serotonin applied peripherally augments pain. 
Its action centrally is important in descending inhibition of incoming 
painful impulses.(10)  
Modulation of pain:  
Pain in the periphery- the nociceptors: 
Most tissues are provided with nociceptors. The quality of 
pain perceived on stimulation of nociceptors, depends on the site 
of stimulation and nature of fibers transmitting the sensation and 
type of stimulation in the periphery, there is a distinction between 
the sharp immediate pain transmitted by delta fibers and prolonged 
unpleasant burning pain mediated through unmyelinated C fibers.  
Nociceptors have different receptors on the surfaces that 
modulate their sensitivity to stimulation, e.g. GABA, opiate, 
bradykinin, histamine, serotonin and capsicin receptors.  
Nociceptors in the periphery lie dormant. Inflammation 
sensitizes a large number of nocieceptors, making then sensitive 
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to stimulation (hyperalgesia). Hyperalgesia may be primary (felt at 
the site of stimulation), related to sensitization of neurons 
innervating that area. It may be secondary (felt at a site remote 
from the original injury related to NMDA).(11)  
Pain and neurotransmiters: 
• Excitatory neurotransmitters: important are glutamate and 
tachykinins. These act at various neurokinin receptors including 
substance P, neurokinin A & B. Other substances that transmit 
pain impulses from incoming nerves in dorsal horn include 
calcitem gene related peptide, vasoactive intestinal polypeptide 
somatostatin and bombesin.  
• Inhibitory neurotransmitters: in the central nervous system 
gamma amino-butyric acid (GABA) are the main inhibitory 
neurotransmitters. 
• Descending pain regulation neurotransmitters: noradrenaline, 
alpha 2 stimulatory effects, serotonin and opiates relief pain by 
stimulating Mu and delta receptors at a host of sites.  
• Specific neurotransmitters:  
a- Glutamate: NMDA receptor mediates a host of spinal 
responses to severe stimulation. These receptors are inactive, 
due to Mg++ present on its ion channels to be remove, Mg++  
adjacent peptide receptors have to be stimulated. Mg++ is 
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removed and painful stimuli occur. Glutamate receptor 
activation results in production of prostanoids and nitric oxide.     
b- GABA: is spread in the brain and the spinal cord, a long with 
glycine. Interneurons in laminae I,II, III are GABA rich, and 
mediate gate control by synapsing on neurons that contain 
substance P. There are several distinct GABA receptors that 
work differently. The GABA A receptor is ligand gated ion 
channel. This allows chloride ions to leak into the cell, while 
GABA B receptor activates G proteins. 
c-  Tachykinins: neurokinin receptor mediate pain in the spinal 
cord. Substance P binds to NK-1 receptor, while neurokinins A 
& B bind respectively to NK-2 and NK-3 receptors. These 
substances are "tachykinins". The tachykinin receptors are G 
protein triggering gene transcription.(12)  
Pain at the cellular level:  
The cellular analogue of viral oncogene, and its cellular 
product, protein (fos); this is important in CNS changes that occur 
when we feel pain. Fos is one of the inducible transcription factors 
(ITFS) that controls mammalian gene expression. This could be a 
molecular marker for pain. C-fos can promote intracellular changes 
including cellular restructuring and proliferation. It is also involved 
in long term neurological consequences of noxious stimulation. 
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This noxious stimulation causes fos to appear in the spinal cord. 
Certain constitutive transcription factors change their activity.  
Brief stimulation (10 min) causes ITFS to appear within 30 
minutes, peak at one-two hours and disappears within 8 hours. 
Prolonged stimulation causes many fold increase in ITFS 
expression. Nociceptive C-fibers stimulation seems to be the main 
stimulus for ITFS production in the spinal cord.  
Prolong stimulation causes C-fos to disappear from spinal neurons 
after 2-7 days. Production of ITFS leads to neuropeptide 
production and synthesis of a variety of receptors. C-Fos is 
involved in cell replication and differentiation.  
Anaesthesia does not suppress production of c-fos within 
the spinal cord. Fentanyl reduces c-fos production by 50% and 
appropriate axial block with local anaesthetic agents can totally 
abolish c-fos response.(12)      
Response to Pain: 
Response to visceral pain is very different from somatic 
pain. Visceral pain results in tonic muscular spasm, while somatic 
pain usually causes withdrawal of affected part of the body, as 
protection from further damage.  
Pain can have profound autonomic effects; there is 
crossover between the somatic and visceral systems at the level of 
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WDR cell in the spinal cord and extensively at higher centers, with 
projections to the hypothalamus.(11)  
Since pain is a subjective and personal experience, its 
tolerance is described as a spectrum of individual experiences to 
the same or similar noxious event. In a study of human patients 
who can verbalize their level of discomfort, it was found that only 
20% of patients felt that their pain experience was what they 
expected. It is therefore, impossible to predict pain levels.(13)  
Adverse effects of pain:  
Pain affects all systems:  
• Respiratory system: in increased skeletal muscle tension 
hypoxaemia occurs. Decreased lung compliance results in 
hypercapnia and ventilation perfusion abnormality.  
• Cardiovascular system: pain leads to increased myocardial work 
(mediated via catecholamines) causes dysarrhythmias, angina, 
myocardial infarction.  
• Endocrine system: pain leads to increase in almost all hormones 
except insulin. Adenocorticotrophic hormone increases results in 
protein catabolism. Increased cortisol leads to lipolysis. 
Decreased insulin leads to hyperglycemia.  
• Pain causes increased platelet adherence and activation of 
coagulation cascade, leading to increased incidence of 
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theromboemeoblic phenomena. In the gentiourinary system, pain 
increases sphincter tone and decreases smooth muscle tone 
leading to urine retention.(14) 
Post-operative pain relief:  
The commonest method of post-operative pain relief is the 
traditional use of on demand intra-muscular opioid injections. 
Postoperative pain is a common clinical problem with many 
adverse reactions. 
 Good post-operative management contributes to 
increased patient's confront as well as decreasing incidence of 
myocardial ischaemia, post-operative pulmonary complications 
and neuro-endocrine stress response. It also allows early 
mobilization of patients.(14)  
Four classes of drugs are useful in management of 
postoperative pain.  
1. Opioids e.g. morphine, pethedine and fentanyl.  
2. Paracetemal and non-steroidal-anti-inflammatory drugs. 
3. Nitric oxide: potent analgesic effective against somatic pain.  
4. Local anaesthetics.  
• Non-pharmacological methods:  
- Cryotherapy: This may be applied to intercostal nerves   exposed 
during a thoracotomy. Nerves are surrounded by ice-                         
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ball produce sub-zero temperature at the end of the probe. 
Neural disruption is temporary and sensation returns after some 
months.(1)  
- Transcutaneous electrical stimulation: (TES): a small alternating 
current is passed between two surface electrodes at low 
voltage, a frequency between 0.2 and 200 HZ. This increases 
CNS concentration of endorphines.(15)  
- Acupuncture: it reduces pain and analgesic consumption 
especially after dental and abdominal surgery. It works in a 
similar manner as TES.(13)     
• Caudal block: Analgesia for most surgical procedures of the 
lower part of the body (mainly below the umbilicus) can be 
provided by caudal block. The indications include herniotomy, 
operations of urinary tract, anus and rectum and orthopedic 
procedures on pelvic girdle and lower extremities.  
- Complications are unusual: They result from misplacement of the 
needle into superficial soft tissues (failure of the block), intra-
vascular or intra-osseous injections (systemic toxicity). Sub-
arachnoid injection (spinal anaesthesia) or even penetration of 
pelvic viscera and vessels. These complications can easily be 
avoided by proper techniques. 
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  Complication include:  
1. Hypertension in patients more than 5 years old.  
2. Delay in voiding, true urinary retention is rare.  
3. Vomiting.  
4. Needle trauma and intraneural injection result in pain.  
5. Systemic toxicity following intravascular injection.  
• Contra-indication:  
1. Infection at puncture site, septicemia, meningitis.  
2. Bleeding disorders.  
3. Allergy to local anaesthetics.  
4. Un-corrected hypovolaemia.  
5. Degenerative axon disease.  
• Anatomy of the sacrum:  
The sacrum is a large triangular bone formed by the fusion 
of the five sacral vertebrae, articulating above with the fifth lumbar 
vertebra and below with the coccyx.  
The posterior surface is convex and down its middle line 
runs the median sacral crest with is three or four rudimentary 
spinous processes. The laminae of the fifth and sometimes of the 
fourth sacral vertebrae fail to fuse in the midline; the deficiency 
thus formed is known as the sacral hiatus. The tubercles 
representing the inferior articular processes of the fifth sacral 
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vertebra are prolonged downwards as the sacral cornua. These 
cornua, with the rudimentary spine of the fourth vertebra above, 
bound the sacral hiatus. Four posterior sacral foramina correspond 
with the anterior foramina. Each transmits a sacral nerve posterior 
ramus and communicates with the sacral canal.  
The apex is directed downwards and articulates with the 
coccyx. The coccyx represents four rudimentary vertebrae 
(sometimes three or five).  
The sacral canal is a prismatic cavity running through the 
length of the bone and following it's curves from the lumber canal 
to the sacral hiatus (closed by the posterior sacrococcygeal 
membrane). Fibrous strands sometimes occur in the canal and 
divide the extradural space into compartments. These may 
account for some cases of failure to produce uniform analgesia. It's 
anterior wall is the sacral vertebrae; it's posterior wall, the laminae. 
Laterally four foramina are present. The anterior wall is sometimes 
very thin, easily pierced by a needle, which then enters marrow 
cavity. Aspiration reveals blood and injected drug rapidly enters 
the venous system.  
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The contents of the sacral canal are as follows:  
1. The dural sac which ends at the upper border of the second 
sacral vertebra, on a line joining the posterior superior iliac 
spines. The pia mater is continued as the filum terminale.  
2. The sacral nerves and the coccygeal nerve, with their dorsal 
root ganglia.  
3. A venous plexus formed by the lower end of the internal 
vertebral plexus. These vessels are more numerous anteriorly 
than posteriorly and so the needlepoint should be kept as far 
posteriorly as possible.  
4. Areolar and fatty tissue-more dense in males than in females.  
The sacral hiatus is a triangular opening, caused by failure 
of the fifth (and sometimes of the fourth) laminar arch to fuse, with 
rounded apex formed by the fourth sacral spine, and a sacral 
cornua in each side below and laterally. It is covered over by the 
sacrococcygeal membrane, which is pierced by the coccygeal and 
fifth sacral nerves and filum terminale. It is superior to the 
sacrococcygeal junction, usually about 3.8 - 5 cm from the tip of 
the coccyx and directly beneath the upper limit of the intergluteal 
cleft.  
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Anatomical abnormalities of the sacrum are not 
uncommon. They include:  
1. Upward or downward displacement of the hiatus;  
2. Pronounced narrowing or partial obliteration of the sacral canal, 
making needle insertion difficult.  
3. Ossification of the sacrococcgyeal membrane;    
4. Absence of the bony posterior wall of the sacral canal, due to 
failure of laminae to fuse.  
5. Dural extension to the level of S3-S4 in 2% of patients, quoted 
by Louis,  or even to the sacrococcygeal membrane itself.  
6. The hiatus may be of many different shapes, ranging from long 
and narrow to broad and shallow. The epidural space deep to it 
may range from being deep to excessively shallow. It may have 
a variable relationship to the tubercles.      
The average capacity of the sacral canal is 34 ml in males 
and 32 ml in females. Its average length is 10-15 cm.  
Technique:  
A needle is inserted through the sacrococcygeal 
membrane at about 90 degrees to the skin surface in females and 
45 degrees in males. Only after penetrating the membrane is the 
needle hub depressed towards the intergluteal cleft and the needle 
is advanced into the sacral canal. Moving the needle in this way 
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before piercing the membrane will lead the needlepoint into the 
subcutaneous tissues rather than the sacral canal. The point must  
not ascends higher than the line joining the posterior superior iliac 
spines and the dura, which ends at this level, be pierced. 
Occasionally (e.g. in children) the dural sac extends lower than S2. 
The mean distance between the apex of the hiatus and the dural 
sac is 4.5 cm.  
After aspiration tests for blood and CSF have been proved 
negative, a test dose can be injected if thought necessary. If blood 
flow back through the needle, its tip is probably in the marrow 
cavity of the body of the vertebra, and must be re-sited correctly in 
the sacral canal. Should CSF appear, a decision must be made 
either to proceed to intradural injection, the proper amount of drug 
being introduced into the theca through the sacral needle, or to 
abandon the technique.  
As a further test of entry to the sacral canal, 1 ml of air 
may be injected via the needle, while an assistant listens over the 
lumbar spine with a stethoscope. A whoosh of air is clearly heard 
via the stethoscope.  
When the needle is correctly placed, injection is easy, no 
great force being required to depress the plunger of the syringe 
(except in patients with spinal stenosis). If the needle is 
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subcutaneous, injection of a few milliliters of air will produce 
surgical emphysema with it's crepitus, or a tumour is raised over 
the sacrum as the injection proceeds (only seen in thin patients). If 
the needlepoint comes to lie between periosteum and bone the 
force needed for injection will be great, a sure sign of an incorrect 
position. The dose is 0.5 -1 ml/kg of 0.25% bupivacaive.  
Actions and clinical pharmacology of bupivacaine: 
Local anesthetics block the generation and the conduction 
of nerve impulses, presumably by increasing the threshold for 
electrical excitation in the nerve, by slowing the propagation of the 
nerve impulse, and by reducing the rate of rise of the action 
potential. In general, the progression of anesthesia is related to the 
diameter, myelination, and conduction velocity of affected nerve 
fibers. Clinically, the order of loss of nerve function is as follows: 
• Pain.  
• Temperature.  
• Touch.  
• proprioception, and  
• skeletal muscle tone. 
Systemic absorption of local anesthetics produces effects 
on the cardiovascular and central nervous systems (CNS). At 
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blood concentrations achieved with normal therapeutic doses, 
changes in cardiac conduction, excitability, refractoriness, 
contractility, and peripheral vascular resistance are minimal. 
However, toxic blood concentrations depress cardiac conduction 
and excitability, which may lead to atrioventricular block, 
ventricular arrhythmias, and cardiac arrest, sometimes resulting in 
fatalities. In addition, myocardial contractility is depressed and 
peripheral vasodilation occurs, leading to decreased cardiac output 
and arterial blood pressure. Recent clinical reports and animal 
research suggest that these cardiovascular changes are more 
likely to occur after unintended intravascular injection of 
bupivacaine. Therefore, incremental dosing is necessary. 
Following systemic absorption, local anesthetics can produce 
central nervous system stimulation, depression, or both. Apparent 
central stimulation is manifested as restlessness, tremors and 
shivering progressing to convulsions, followed by depression and 
coma progressing ultimately to respiratory arrest. However, the 
local anesthetics have a primary depressant effect on the medulla 
and on higher centers. The depressed stage may occur without a 
prior excited state.  
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Pharmacokinetics:  
The rate of systemic absorption of local anesthetics is 
dependent upon the total dose and concentration of drug 
administered, the route of administration, the vascularity of the 
administration site, and the presence or absence of epinephrine in 
the anesthetic solution. A dilute concentration of epinephrine 
(1:200,000 or 5 mcgm/mL) usually reduces the rate of absorption 
and peak plasma concentration of marcaine, permitting the use of 
moderately larger total doses and sometimes prolonging the 
duration of action. The onset of action with marcaine is rapid and 
analgesia is long lasting. The duration of analgesia is significantly 
longer with marcaine than with any other commonly used local 
anesthetic. It has also been noted that there is a period of 
analgesia that persists after the return of sensation, during which 
time the need for strong analgesics is reduced. The duration of 
anesthetic effect is prolonged by the addition of epinephrine 
1:200,000. Local anesthetics are bound to plasma proteins in 
varying degrees. Generally, the lower the plasma concentration of 
drug the higher the percentage of drug bound to plasma proteins.   
Depending upon the route of administration, local 
anesthetics are distributed to some extent to all body tissues, with 
high concentrations found in highly perfused organs such as the 
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liver, lungs, heart, and brain. Pharmacokinetic studies on the 
plasma profile of bupivacaine after direct intravenous injection 
suggest a three-compartment open model. The first compartment 
is represented by the rapid intravascular distribution of the drug. 
The second compartment represents the equilibration of the drug 
throughout the highly perfused organs such as the brain, 
myocardium, lungs, kidneys, and liver. The third compartment 
represents an equilibration of the drug with poorly perfused 
tissues, such as muscle and fat. The elimination of drug from 
tissue distribution depends largely upon the ability of binding sites 
in the circulation to carry it to the liver where it is metabolized.  
After injection of bupivacaine for caudal, peak levels of 
bupivacaine in the blood are reached in 30 to 45 minutes, followed 
by a decline to insignificant levels during the next three to six 
hours. Various pharmacokinetic parameters of the local 
anaesthetics can be significantly altered by the presence of 
hepatic or renal disease, addition of epinephrine, factors affecting 
urinary pH, renal blood flow, the route of drug administration, and 
the age of the patient. The half-life of marcaine (bupivacaine) in 
adults is 2.7 hours and in neonates 8.1 hours.  
Amide-type local anaesthetics such as marcaine are 
metabolized primarily in the liver via conjugation with glucuronic 
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acid. Patients with hepatic disease, especially those with severe 
hepatic disease, may be more susceptible to the potential toxicities 
of the amide-type local anaesthetics. Pipecoloxylidine is the major 
metabolite of marcaine.  
The kidney is the main excretory organ for most local 
anesthetics and their metabolites. Urinary excretion is affected by 
urinary perfusion and factors affecting urinary pH. Only 6% of 
bupivacaine is excreted unchanged in the urine. When 
administered in recommended doses and concentrations, 
MARCAINE does not ordinarily produce irritation or tissue damage 
and does not cause methemoglobinemia.  
Indications and usage:  
Bupivacaine is indicated for the production of local or 
regional anesthesia or analgesia for surgery, diagnostic and 
therapeutic procedures. Only the 0.25% and 0.5% concentrations 
are indicated.  
 Bupivacaine hydrochloride:  
Bupivacaine is a long acting, amide type local anesthetic 
chemically related to lignocaine and mepivacaine. It is 
approximately four times as potent as lignocaine.    
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Physical properties:   
•  Bupivacaine is presented in different concentrations. 
It is a clear, colourless, particle-free solution, with pH 
4.0-6.5.  
•  Bupivacaine + Adrenaline is a clear, colourless, 
particle-free solution containing metabisulphite, with 
pH 3.3-5.0, metabisulphite may cause allergic-type 
reactions including anaphylactic symptoms and life-
threatening or less severe asthmatic episodes in 
certain susceptible people. 
•  Bupivacaine should be stored at 25°C or below. Do 
not freeze.  
• The ampoules are designed for single use only; any 
unused portions of solutions should be discarded.    
Pharmacokinetics:  
Bupivacaine has a pKa of 8.1 and a high degree of lipid 
solubility with an oil/water partition coefficient of 27.5. It is mainly 
bound to alpha-1-acid glycoprotein in plasma with plasma binding 
of 96%. These factors contribute to its prolonged duration of 
action.  
The rate of absorption and plasma concentration of 
bupivacaine depends upon the dose, the route of administration 
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and the vascularity of the injection site. Absorption may be slowed 
by the addition of adrenaline. In concentrations of 5 mg/ml, it has a 
long duration of action, from 2-5 hours following a single epidural 
injection and up to 12 hours after peripheral nerve blocks.  
When used in low concentrations (2.5 mg/ml or less) there 
is less effect on motor nerve fibres and the duration of action is 
shorter. Low concentrations may, however, be used with 
advantage for prolonged pain relief, e.g. in labour or 
postoperatively. Absorption of bupivacaine from the epidural space 
occurs in 2 phases; the first phase is in the order of 7 minutes and 
the second is in 6 hours, the slow absorption is rate limiting in the 
elimination of bupivacaine, which explains why the apparent 
elimination half-life after epidural administration is longer than after 
intravenous administration. Bupivacaine has a total plasma 
clearance of 0.58 L/min, a volume of distribution at steady state of 
73 L, an elimination half-life of 2.7 h and an intermediate hepatic 
extraction ratio of 0.4 following experimental IV administration in 
adults. The terminal elimination half-life is prolonged in the 
newborn to approximately 8 hours. In children over 3 months, the 
elimination half-life is similar to that in adults. Bupivacaine readily 
crosses the placenta and is excreted in breast milk in 
concentrations lower than the maternal plasma concentration.  
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Hepatic and renal disease, route of administration, age of 
the patient and certain concomitant medication can change the 
pharmacoketic parameters.  
Metabolism of Bupivacaine:  
Bupivacaine is metabolized in the liver and excreted via 
the kidneys, the possibility of bupivacaine accumulation should be 
considered in patients with hepatic and/or renal impairment. 
Bupivacaine is excreted in the urine principally as metabolites with 
about 6% as unchanged medicine and approximately 5% at the      
N-dealkylated metabolite, pipecolylxylidine (PPX). Following 
epidural administration, the urinary recovery of unchanged 
bupivacaine is about 0.2%, of pipecolylxylidine (PPX) about 1% 
and 4-hydroxy- bupivacaine about 0.1% of the administered dose.   
Mode of Action:  
Bupivacaine, like other local anesthetics, causes a 
reversible blockade of impulse propagation along nerve fibres by 
preventing the inward movement of sodium ions through the nerve 
membrane. Local anaesthetics of the amide type are thought to act 
within the sodium channels of the nerve membrane.  
Given as a spinal anaesthetic, bupivacaine has a rapid 
onset and a medium to long duration. The duration is dose-
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dependent. It is approximately four times more potent and toxic 
than lignocaine.  
Indications:  
• Analgesia in labour,  
• Post-operative analgesia.   
• Other therapeutic pain blocks, particularly where long-acting 
anaesthesia is required.  
• Surgical anaesthesia.  
Contraindications:  
1. Allergy or hypersensitivity to amide type local anaesthetics or 
sodium metabisulphite in adrenaline-containing solutions.  
2. Obstetric paracervical block, intravenous regional anaesthesia 
(Bier's block) and all intravenous infusions.  
3. The following are additional contraindications for solutions with 
Adrenaline:  
Adrenaline is contraindicated in conditions where the 
production or exacerbation of tachycardia could prove fatal such 
as:   
•  Thyotoxicosis.  
•  severe heart disease. 
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•  in obstetrics when maternal blood pressure exceeds 140/90 
mm Hg  
•  Adrenaline-containing solutions must not be used for 
analgesia in parts of the body with compromised blood supply 
or supplied by end arteries, such as fingers, toes, nose, ears 
or penis. There is a possibility of producing arterial 
vasoconstriction and subsequent ischaemic gangrene distal 
to the site of injection.   
Side effects:  
Cardiovascular: hypotension, bradycardia, arrhythmias and 
cardiac arrest may occur.  
Respiratory: difficulty in breathing, apnoea and respiratory failure 
may be precipitated.  
Central Nervous system: CNS manifestations are excitatory 
and/or depressant and may be characterized by light-headedness, 
tinnitus, nervousness, apprehension, euphoria, confusion, 
dizziness, drowsiness, blurred vision, vomiting, sensations of heat, 
cold or numbness, twitching, agitation, difficulty in swallowing, 
slurred speech, tremor, convulsions, unconsciousness.  
Allergy: it may be presented as allergic der matitis, bronchospasm 
or anaphylaxis.   
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Acute systemic toxicity: It occurs in accidental intravascular 
injections and over dosage. The early features are circumoral 
paraesthesia, numbness of the tongue, light-headedness, 
hyperacusis and tinnitus, followed by cardiovascular and 
respiratory failure.    
Precautions:  
Caution in the presence of hepatic insufficiency, impaired 
cardiovascular function (severe bradycardia, cardiac conduction 
disturbances, severe shock and heart block), epilepsy and        
pre-existing abnormal neurological or neuromuscular disease. 
Reduction of the dosage in elderly, debilitated patients and in 
peadiatric patients.    
 
Presentation:  
Marcain ± Adrenaline 
Bupivacaine hydrochloride with and without adrenaline.  
•  0.125% infusion-a clear, colourless, particle-free solution 
containing. 1.25 mg/ml bupivacaine HCl, 8.5 mg/ml sodium 
chloride, with pH 4.0-6.5.  
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•  0.25% injection and infusion-a clear, colourless particle-free 
solution containing. 2.5 mg/ml bupivacaine HCl, 8 mg/ml 
sodium chloride, with pH 4.0-6.5.   
•  0.37% injection -a clear, colourless particle-free solution 
containing. 3.75 mg/ml bupivacaine HCl, 8 mg/ml sodium 
chloride, with pH 4.0-6.5.   
•  0.5% injection -a clear, colourless particle-free solution 
containing. 5 mg/ml bupivacaine HCl, 8 mg/ml sodium chloride, 
with pH 4.0-6.5.   
•  0.25% injection plus adrenaline 1:400,000 -a clear, colourless 
particle-free solution containing 2.5 mg/ml bupivacaine HCl, 8 
mg/ml sodium chloride, 4.5 mcg/ml adrenaline acid tartrate, 0.5 
mg/ml sodium metabisulphite, with pH 3.3-5.0.   
•  0.5% injection plus adrenaline 1:200,000 -a clear, colourless 
particle-free solution containing 5 mg/ml bupivacaine HCl, 8 
mg/ml sodium chloride, 9.1 mcg/ml adrenaline acid tartrate, 0.5 
mg/ml sodium metabisulphite, with pH 3.3-5.0. 
Paracetamol: 
Paracetamol is widely used in the management of pain 
and fever in children, having gained ascendancy after the reported 
association between Reye's syndrome and aspirin in the 1980s. 
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The drug is an effective antipyretic at plasma concentrations of 
0.066-0.130mmol/l and it is assumed that analgesia occurs in a 
similar range. This is unproven. The analgesic effect of 
paracetamol is thought to be directly related to its plasma 
concentration, because of its high lipid solubility and low protein 
binding. Paracetamol is a weak acid with a high pKa and, in the 
alkaline medium of the duodenum, it is non-ionised and rapidly 
absorbed. Paracetamol absorption is used as a measure of gastric 
emptying. The hepatic extraction ratio is less than 0.3. 
Paracetamol is the most common drug prescribed in paediatric 
practice. In our own hospital, approximately 50% of inpatient 
children are prescribed this medication.(17) 
Pain Relief from Paracetamol:   
A direct relationship between plasma paracetamol levels 
and analgesia has been established in a rat model. Uric acid was 
injected into the knee joint of the hind limb, to act as nociceptive 
stimulus. The animals were then given paracetamol in doses of up 
to 562 mg/kg and recovery of function over time was considered 
as an expression of analgesia. 
In adult human volunteer studies, paracetamol is superior 
to placebo as an analgesic. Both 0.5 g and 1g immediate release 
paracetamol were superior to placebo for one to five hours after 
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experimental pain induced by brief cutaneous application of argon 
laser pulses. The analgesic effect was assessed as a change in 
pricking pain threshold and no difference in analgesic effect was 
noted between these doses. In a further study, comparing 
paracetamol lg, paracetamol 1g plus codeine 60mg and placebo, 
pain threshold and brain evoked potentials to laser stimulation 
were assessed for six hours.  The pain threshold was significantly 
elevated one and two hours after paracetamol ingestion. 
Paracetamol l g plus codeine 60 mg was superior to placebo for up 
to six hours after medication.  
This view is supported by Rusy,(17) who demonstrated low 
or even undetectable serum paracetamol concentrations in the first 
40 minutes after surgery, when rectal paracetamol 30-35 mg/kg 
had been administered intraoperatively. Mather(17) demonstrated a 
need to supplement rectal paracetamol 20 mg/kg with a 
nonsteroidal anti-inflammatory agent to achieve satisfactory 
analgesia. Adequate analgesia in children undergoing surgery has 
been described using preoperative oral paracetamol in a dose of 
40 rng/kg. The cumulative frequency of children having satisfactory 
pain scores increased to a ceiling of 66% at a plasma paracetamol 
concentration of 0.25 mmol/l. Few additional children achieved 
analgesia with higher plasma concentrations.  
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Toxicity:  
Hepatic toxicity is reported with plasma concentrations 
above 0.8 mmol/1 after acute poisoning. Concern about toxicity is 
the main reason for reticence among practitioners to prescribe 
higher than traditional doses of paracetamol. Paracetamol 
overdose results in increased production of highly reactive 
electrophilic arylating metabolites by the hepatic cytochrome P-
450-dependent mixed function oxidase enzyme system. These 
metabolites bind to intracellular hepatic macromolecules to 
produce cell necrosis and damage. Paracetamol may accumulate 
in paediatric patients after repeated therapeutic doses. There is 
evidence, from adults, of glutathione depletion in volunteers given 
doses of 0.5 g and 3 g paracetamol separated by four to ten days. 
Penna and Buchanan20 reported seven deaths and 11 cases of 
hepatotoxicity associated with paracetamol poisoning in children. 
Mortality due to hepatotoxicity was associated with doses greater 
than 300 mg/kg/day for one to six days. Survival was usually seen 
in those children suffering hepatotoxicity due to paracetamol in 
doses greater than 150 mg/kg/day for two to eight days. Current 
guidelines recommend that doses should not exceed 90 
mg/kg/day. 
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Infants:  
Out of the neonatal period, the metabolism of paracetamol 
by infants is similar to older children (T1/2b 2.1, CI 0.365 l/kg/h). 
Recommended dosage regimes are conservative (60 mg/kg/day), 
again reflecting the lack of well conducted pharmacokinetic 
studies. 
Lag times between concentration and effects:  
Paracetamol is thought to have an analgesic effect via 
NMDA receptors in the spinal cord. Nielsen et al and Ariendt-
Nielson et al(17) demonstrated a one hour delay between peak 
plasma paracetamol concentrations and maximum analgesia. 
Similarly, there is a 100 minute lag between peak plasma 
paracetamol concentration and peak temperature reduction. 
Cerebrospinal fluid concentrations of paracetamol mirror those in 
plasma with a similar time delay.  It is thus prudent to administer 
paracetamol at least 1 hour orally or 2 hours rectally before a 
surgical insult.  
The dose of paracetamol used in this study is 20 mg/kg, 
put in rectum in the lithotomy position after induction of 
anaesthesia.  
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Summary:  
Paracetamol remains the stalwart of paediatric analgesia, 
despite limited evidence of efficacy. Concern about hepatotoxicity 
has resulted in cautious perioperative dosing regimes, but both 
pharmacokinetic and pharmacodynamic data have shown these 
doses to be inadequate. While there is increasing evidence that a 
single rectal loading dose of 20 mg/kg results in more desirable 
plasma paracetamol concentrations, caution must be taken not to 
exceed the current recommended daily dosing of 90 mg/kg/day.(17)  
Previous studies: 
A study done by TCK, and Roos showed that caudal block 
is the most commonly performed paediatric block for providing 
postoperative pain control for ambulatory surgery in children. 
Features of paediatric anatomy and physiology allow successful 
performance of the techniques.(18)  
Another study done by Nielsen and Steels showed that 
regional analegesia in children provides a continuum of 
perioperative care that include peri-operative pain management, 
decreased opioid requirements, decreased postoperative nausea 
and vomiting. In addition regional analgesia has been shown to 
improve the cardiovascular, pulmonary, gastro-intestinal, 
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coagulative, immunological and cognitive functions. And to be of 
benefit of economic context.(19)   
A study done by Wucl and Caldwell revealed thay the 
pathophysiology that commonly followed surgery result in 
detrimental physiological effects and may be associated with 
postoperative morbidity and mortality. The use of epidural 
analgesia but not systemic opioid may attenuate these effects and 
facilitate return of gastro-intestinal function, attenuate hyper-
coagulable events and decrease postoperative pulmonary 
complications. And also facilitate patient recovery.(20)  
In a double blind study done by Batra, Prasad, Arya, Chari 
and Yaddanapudi comparing caudal marcaine and tramadol in 
postoperative pain score and side effects. The result point towards 
a significantly lower pain score with marcaine and also vomiting is 
less frequent.(21)  
 
A study of Dieng, Diouf and Diene showed that caudal 
marcaine is safe and secure procedure. Give pain relief even in 
painful procedures and good postoperative status with only some 
minor complications.(22)  
A study done by Seymour showed that rectal paracetamol 
is an effective anagesic for controlling postoperative pain.(23)    
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OBJECTIVES 
 
1. To assess the quality of analgesia when using caudal 
bupivacaine or rectal paracetamol. 
2. Duration of analgesia of caudal bupivacaine and rectal 
paracetamol. 
3. Side effects of caudal bupivacaine and rectal paracetamol. 
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PATIENTS AND METHODS 
 
• Study site:  
This study was performed in Soba university hospital in the 
period from 10th of March to 29th of September 2003. The 
availability of patient and the well-equipped theatre were the main 
reasons for selecting this hospital as study area.  
The study has been approved by the ethical committee of 
the Faculty of Medicine and the patient's parents verbal consent 
were obtained.  
• Study population:  
A prospective study was performed on 100 patients 
presenting for different elective surgeries (herniotomies, 
hydroceles, vesical stones, un-descended testes, hypospadius, 
lower limb orthopedic surgery etc ...). The operations were done 
under general anesthesia using inhalation induction by halothane, 
suxamethonium for intubation. Maintenance by halothane and 
pancuronium together with oxygen and nitrous oxide, spontaneous 
or controlled ventilation.  
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• Study design:  
The study utilized the experimental research design and 
the 100 patients included in the study were divided into two 
groups.  
- Group A: consisted of 50 patients given caudal bupivacaine, 
dose 0.5 ml/kg of 0.25% bupivacaine.  
- Group B: consisted of 50 patients given rectal paracetamol, 
dose 20 mg/kg.  
• Inclusion Criteria:  
1- Patients of ASA grade I and II.  
2- Patients age between 1-12 years old.  
3- Patients under going elective infra-umbilical surgery.   
• Exclusion Criteria:   
1- Patients of ASA grade III, IV, V. 
2- Patients less than one year old and more than 12 years old.  
3- Patients with neurological deficit in lower limbs.  
4-  Patients with malformation of the vertebral column.  
5- Patients with sepsis at the site of caudal black.  
6- Patients with bleeding disorders.  
7- Patients with allergy to paracetamol or local anaesthetic.  
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•   General characteristics of patients: 
These were obtained from history and examination and 
were recorded. They include age, weight and blood pressure. All 
parents were asked about the past medical and anaesthetic history 
of their children (whether the patients had any complications 
following previous anaesthetic exposure). A full physical 
examination to all patients was conducted during pre-operative 
assessment and routine pre-operative investigations were 
observed.  
• Data collection:  
The data collected included the following parameters:  
1. Drug used: caudal marcaine or rectal paracetamol.   
2. Duration of analgesia.  
3. Assessment of post-operative analgesia by pain and 
discomfort evaluation score (PDES) (appendix)  
4. Need for pain killer.  
5. Level of systolic blood pressure. 
6. Complications.   
All of the observations were recorded in the patient's 
charts. All drugs that were given to the patients throughout the 
operation and till recovery were recorded in the anaesthetic sheet.  
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Techniques:  
• Caudal bupivacaine: after induction of general anaesthesia. 
Patient tilted to the left side, sacral hiatus identified at the 
midline by palpation, I washed my hands and wear gloves. The 
back washed with bovidone and spirit. Bupivacaine 0.5 ml/kg 
(0.25%) prepared in syringe, 21 gauge needle applied to the 
syringe and skin penetrated at 30 degree, cephalad direction at 
the sacral hiatus until I felt piercing sacrococcygeal membrane.  
Aspiration test was done if no blood or CSF obtained, then the 
drug injected slowly. 
• Rectal paracetamol: after induction of general anaesthesia, the 
patient put in the lithotomy position, after washing hands and 
wear gloves. Paracetamol suppository was put in the rectum (20 
mg/kg).  
• Assessment of pain postoperative done every 15 min for one 
hour and then after 2 hours, 8 hours by anaesthesia registrar 
with collaboration with the surgical registrar on duty.  
• The need for postoperative analgesia decided by both registrars 
according to the severity of pain.  
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RESULTS  
This study included 100 patients divided equally into two 
groups according to the type of analgesia received. The groups 
were categorized into caudal bupivacaine and rectal paracetamol. 
The age of patients ranged from 1-12 years mostly from 2-4 years  
(Table I).  
The male patients were 76% , 54% received caudal 
bupivacaine while 46% received rectal paracetamol. The female 
patients were 24%, 37% received caudal bupivacaine while 63% 
received rectal paracetamol. (Table2) 
There were no statistical differences between the two 
groups regarding age, gender (P >0.05) (Table II) and duration of 
surgery (Table III).  
Eighteen percent of patients who received caudal 
bupivacaine needed systemic analgesia in the first 24 hrs, 44.4% 
of them received I.M pethedine, while 55.6% received oral 
paracetamol (Table 4).  
18% of patients who received caudal bupivacaine need 
supplementary analgesia, 44.4% received I.M pathedine while 
55.6% received oral paracetamol. 
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46% of patints who received rectal paracetamol needed 
systemic analgesic, 60.8% of them received I.M pethedine . 39.2% 
received oral paracetamol. (Table 5) 
33.3% of patients who received caudal bupivacaine need 
supplementary analgesia within the first 8 hours while 66.7% of 
them need after the first 8 hours. 
36% of patients who received rectal paracetamol need 
supplementary analgesia within the first 8 hours, while 46% of 
them need after the 8 hours. (Table 6) 
Comparing patients’ satisfaction in relation to type of 
analgesia, there was significant difference between the two 
groups. Patients who received caudal bupivacaine were more 
satisfied than those who received rectal paracetamol.  
The complications of caudal bupivacaine encountered by 
16% of patients is pain at the site of injection. No complications 
were encountered related to rectal paracetamol. (Table 7)                                      
The patients understudy had undergone various types of 
surgeries most lasting between 30-45 minutes (Figure 1). 
Manifestations noted after surgery were changes in systolic blood 
pressure, weeping, movements, anxiety, posture and pain 
complaint. Most groups showed no significant deviation from 
normal (Figure 2).  
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Pain was evaluated using pain and discomfort evaluation 
scores (PDES): Sixty percent of patients receiving caudal 
bupivacaine scored < 3.  Twenty-six percent scored from 3 - 6 and 
14% scored more than 6 (Figure 3). 
60% of patients receiving caudal bupivacaine, undergoing 
urogenital surgery scored less than 3 while 26% of patients scored 
from 3- 6. 14% of patients scored from 6- 12. (Figure 4) 
45.5% of patients receiving rectal paracetamol, undergoing 
urogenital sergery  scored < 3. 28.6% of patients scored between 
3- 6. 25% of patients scored between 6- 12. (Figure 5) 
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Table (1): Age (in years) distribution among the patients 
 in the two groups: 
group 
Age (years) 
Caudal 
bupivacaine 
Rectal 
paracetamol 
Total 
< 2 8 (16%) 9 (18%) 17 (17%) 
2 - 4 14 (28%) 17 (34%) 31 (31%) 
4 - 6 9 (18%) 6 (12%) 15 (15%) 
6 - 8 8 (16%) 7 (14%) 15 (15%) 
8 - 10 6 (12%) 7 (14%) 13 (13%) 
> 10 5 (10%) 4 (8%) 9 (9%) 
Total 50 50 100 (100%) 
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Table (2): sex distribution among patients in the two groups. 
group 
Sex 
Caudal 
bupivacaine 
Rectal 
paracetamol 
Total 
Male  41(82%) 35 (70%) 76 (76%) 
Female  9 (18%) 15 (30%) 24 (24%) 
Total  50 50 100 (100%) 
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Table (3): Duration of surgery among two groups. 
Group 
Duration  
Caudal 
bupivacaine 
Rectal 
paracetamol 
Total 
< 15 min  3             
6% 
5             
10% 
8             
8% 
15 -30 min  14            
28% 
15            
30% 
28           
29% 
30 - 45 min  22            
44% 
19            
38% 
41            
41% 
45 - 60 min  7             
14% 
8             
16% 
15            
15% 
> 60 min 4             
8% 
3             
6% 
7             
7% 
Total   50 50 100 
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Table (4): Need of post-operative analgesia in the 
 first 24 hours among the two groups. 
                  Group 
Need of pain killer 
Caudal 
bupivacaine 
Rectal 
paracetamol 
Total 
Yes  9 (18%) 23 (46%) 32 
No  41 (82%) 27 (54%) 68 
Total  50 50 100 
 
P < 0.05 
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Table (5): Need of intramuscular pethedine and oral 
paracetamol  among the two groups. 
group 
analgesic  
Caudal 
bupivacaine 
Rectal 
paracetamol 
Total 
I. M pethedine  4 (44.4%) 14 (60.8) 18 (56.25%) 
Oral paracetamol  5 (55.6%) 9 (39.2%) 14 (43.75%) 
Total        9       23     32 
 
P > 0.05 
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Table (6): Time of administration of intramuscular pethedine  
and oral paracetamol among two groups. 
Group 
Time 
Caudal 
bupivacaine 
Rectal 
paracetamol 
Total 
In first 8 hrs 3 (33.3%) 8 (36%) 11 (34.3%) 
After first 8 hrs  6 (66.6%) 15 (64%) 21(65.7%) 
Total 9 23 32 
 
P < 0.05 
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Table (7): Complications of caudal bupivacaine and  
rectal paracetamol among two groups. 
Group  
Duration  
Caudal 
bupivacaine
Rectal 
paracetamol 
Total 
Pain at site of injection  8 (16%) 0 8 
No complication  42 (84%) 50 92 
Total  50 50 100 
 
P < 0.05 
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DISCUSSION  
This study compared the postoperative analgesic effect of 
caudal bupivacaine and rectal paracetamal.  
Pain assessment, duration of analgesia and complications 
were the aspects studied. 
The age of patients range from 1- 12 years.  
Regional analgesia is being  increasingly integrated in the 
strategy of pain management covering the pre, intra and post-
operative period specially in paediatrics  
Regional anaesthesia has an established role in 
paediatrics anaesthesia. New development were increase it's role 
incoming years for intra and post-operative management. 
Peripheral nerve blocks remain under used inspite of their 
advantages both in term of safety and efficacy. 
In this study we demonstrated caudal bupivacaine (0.5 ml/ 
Kg 0.25 %) produce adequate analgesia in infra-umblical surgery 
in paediatrics. To calculate the necessary volume and dosages of 
the anaesthetic we used the formula 0.5 ml /kg. 
For rectal paracetamol we used the formula 20 mg/kg. 
In our study, the dose and volume of anaesthetic was 
enough to provide adequate analgesia without complications. All 
 62
doses utilize were below that might lead to dangerous plasma 
level. 
The changes in systolic and diastolic blood pressure were 
minimal. This because the vascular tone is less in children than 
adults(24). Heart rate was kept at normal. Regional anaesthesia 
eliminate the bradycardia  response to mesenteric or spermatic 
cord manipulation during uro-genital or lower abdominal surgery. 
Age, weight and sex are not limiting factors for the 
administration of the techniques(25). We observed that the younger 
the patient the more effective the analgesia is. 
The opinion of the paediatric surgeons about the regional 
analgesic technique varied between good and excellent. Caudal 
bupivacaine has the advantage that the block is more effective 
within the first 8 hours. (Table 6)    
The majority of studies concerning postoperative analgesia 
in pediatrics showed that these drugs provide effective analgesia 
in pediatrics in different surgical procedures.(18,19,2021) Caudal 
bupivacaine reduced postoperative opioid consumption.  
Eighteen percent of patients who received caudal 
bupivacaine needed systemic analgesia in the first 24 hrs, 44.4% 
of them received 1.M pethedine, while 55.6% received oral 
paracetamol (Table 4).  
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33.3% of patients received analgesic within the first            
8 hours, while 66.6% needed analgesia after 8 hours.  
46% of the patients who received rectal paracetamol 
needed systemic analgesic 60.8% of them received I.M pethedine. 
66% within the first 8 hours, 39.2% received oral paracetamol. 
36% of them within first 8 hours. 46% received analgesic after first 
8 hours.  
 
The study by ECK and Roos showed that caudal block is 
most commonly performed in paediatrics for providing 
postoperative pain control. The need for postoperative analgesia is 
only 8.4%. They gave intramuscular morphine.(18)  
Another study done by Nielsen and Steels should that 
regional analgesia in children provides a continuum of 
perioperative care that include perioperative pain management, 
decreased opioid requirements, decreased post-operative nausea 
and vomiting. In addition regional analgesia has been shown to 
improve the cardiovascular, pulmonary, gastro-intestinal, 
coagulative, immunological and cognitive functions. And to be of 
benefit of economic context. (19) 
A study done by Wucl and Caldwell revealed that the 
pathophysiology that commonly followed surgery result in 
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detrimental physiological effects and may be associated with post-
operative morbidity and mortality. The use of epidural analgesia 
but not systemic opioid may attenuate these effects and facilitate 
return of gastro-intestinal function, attenuate hyper-coagulable 
events and decrease post-operative pulmonary complications. And 
also facilitate patients recovery. (20) 
In a double blind study done by Batra, Prasad, Arya, Chari 
and Yaddanapudi comparing caudal marcaine and tramadol in 
post-operative pain score and side effects. The result point 
towards a significantly lower pain score with marcaine  and also 
vomiting is less frequent. (21) 
A study of Deing, Diouf and Diene showed that caudal 
marcaine is safe and secure procedure. Give pain relief even in 
painful procedures and good post-operative status with only some 
minor complications. (22) 
A study done by Seymour showed that rectal paracetamol 
is an effective analgesic for controlling post-operative pain. (23) 
The only complication encountered by patients who 
received caudal bupivacaine is pain at the site of injection felt by 
16% in this study. In study of Nielsen and steels it was 
encountered in 4% only.(19)    
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In this study, caudal bupivacaine proved to be more 
effective in postoperative pain relief in children than rectal 
paracetamol but it was associated with a significant incidence of 
pain at the site of injection.      
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CONCLUSION 
  
1.  Caudal bupivacaine is significantly more effective than rectal 
paracetamol in postoperative analgesia in pediatrics, it 
reduces analgesic requirements.  
2. Rectal paracetamol is associated with less complications in 
comparison with caudal bupivacaine. 
3. The time of administration of the conventional analgesic given 
post-operatively showed no significant difference between 
caudal bupivacaine and rectal paracetamol. 
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RECOMMENDATIONS  
 
1. Postoperative analgesic techniques done intra-operatively 
reduce postoperative pain and it's adverse effects and should 
be practiced more widely.  
2. Caudal bupivacaine is more effective than rectal paracetamol 
for postoperative analgesia, so it is highly recommended.  
3. Further studies regarding  the dose  and time of administrations 
should be carried out.  
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Table  show Pain and Discomfort Evaluation Score (PDES) 
 
Parameters Criteria  Score 
Blood pressure up to 20% of preoperative values  
20 - 30% of preoperative values  
> 30% of preoperative values  
0 
1 
2 
Weeping  Without weeping  
Weeping, responding to kindness 
Weeping, not responding to kindness 
0 
1 
2 
Movement  None 
Unquiet 
Agitated 
0 
1 
2 
Anxiety Sleeping or calm  
Moderate  
Very anxious 
 
 
0 
1 
2 
Posture  Without specific posture  
Flexion of legs and thighs  
Holding the operated site 
0 
1 
2 
Pain complaint  No pain  
Non-localized pain 
Localized pain 
0 
1 
2 
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Questionnaire 
Postoperative analgesia in pediatrics patients undergoing infra-umbilical 
surgery: a comparative study between Caudal Marcaine and the Rectal 
Paracetamol 
 
• Case No........................................... 
• Patient's Name: ……………….................................………… 
•  Weight: ………………….....kg       
• Operation: …………………....… •Duration of surgery: ……...…… 
• Type of analgesia:   
                                  - Caudal Marcaine                   - Rectal paracetamol  
• Time of administration  ……………………………………………… 
• Assessment of pain  ……………………….......……………………… 
PDES Scores  
Time / min  Score Time / min  Score 
15  120  
30    
45    
60    
 
• Analgesic need during the 1st 24 hours:         
                                    - Yes                               - No 
• If  "Yes":    
      - Drug:  ................................ Route:  ................................ Time:.................                     
 
